Ideas to Action:
Independent research for global prosperity
Drugs created with billions in government support, bought almost exclusively by governments and international agencies are shrouded in secrecy: who is paying how much for delivery of what by when is a matter of guesswork and estimate.
Here are four additional policy priorities for the Biden-Harris administration’s to-do list.
Charles Kenny launches his latest book The Plague Cycle: The Unending War Between Humanity and Infectious Disease.
From our CGD family to you and yours, we wish you a happy holiday season and a healthier and happier 2021. And, let me offer an enthusiastic farewell to 2020.
We’ve picked our favourite papers and articles about development of the year, picking pieces that help us understand the problems we’re working on better and how best to fix them.
Today we launch an interactive tool that analyses the COVID-19 vaccine portfolio, and generates estimates about the timelines for the vaccines in the portfolio.
This blog unveils a framework that can help policymakers move to a holistic COVID-19 response that accounts for the impacts of the pandemic and the measures implemented to fight it.
With COVID-19 set to lead to a major upsurge in those living in extreme poverty and the wider developing world, the new CDI provides looks at how 40 of the world’s most powerful countries are contributing on health-related policies and commitments.
DFIs are well positioned to address five pressure points in the COVID-19 response that need financing. Let’s unpack these one by one.
Virtually all countries in the world have responded to the COVID-19 crisis by implementing fiscal and monetary measures, significantly larger in relation to national output than those employed during the 2008 financial crisis. The magnitude of fiscal measures to counter the shock varies across developing and advanced economies.
Commentary Menu